Left Main Percutaneous Coronary Intervention Registry in Istanbul Medipol University Hospital

NCT06262971 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3620

Last updated 2024-02-16

No results posted yet for this study

Summary

This hospital-based registry study at Istanbul Medipol University Hospital focuses on documenting and analyzing the clinical and demographic characteristics, procedural-related aspects, and both short and long-term outcomes of patients undergoing left main coronary artery percutaneous coronary intervention (PCI). The study aims to identify predictors for adverse clinical outcomes in patients treated for left main coronary artery disease.

Conditions

Interventions

DEVICE

Percutaneous coronary intervention

balloon angioplasty, stent implantation, atherectomy, intravascular ultrasound.

Sponsors & Collaborators

  • Medipol University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-01
Primary Completion
2022-12-31
Completion
2023-12-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06262971 on ClinicalTrials.gov